日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression.

贝伐珠单抗通过抑制 survivin 表达来增强肝细胞癌对阿霉素的化疗敏感性

Xiong Yu-Quan, Sun Hui-Chuan, Zhu Xiao-Dong, Zhang Wei, Zhuang Peng-Yuan, Zhang Ju-Bo, Xu Hua-Xiang, Kong Ling-Qun, Wu Wei-Zhong, Qin Lun-Xiu, Tang Zhao-You

Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma.

长期使用干扰素-α治疗可抑制肝细胞癌的肿瘤生长,但会促进其转移能力

Zhuang Peng-Yuan, Zhang Ju-Bo, Zhang Wei, Zhu Xiao-Dong, Liang Ying, Xu Hua-Xiang, Xiong Yu-Quan, Kong Ling-Qun, Wang Lu, Wu Wei-Zhong, Tang Zhao-You, Qin Lun-Xiu, Sun Hui-Chuan

Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival

血管内皮生长因子及其受体的蛋白表达谱分析可识别肝细胞癌的亚型并预测生存率

Jia, Jin-Bin; Zhuang, Peng-Yuan; Sun, Hui-Chuan; Zhang, Ju-Bo; Zhang, Wei; Zhu, Xiao-Dong; Xiong, Yu-Quan; Xu, Hua-Xiang; Tang, Zhao-You